|Articles|June 1, 2016
Scaling-Up from Lab to Commercial Scale
Advertisement
Nicolle Courtemanche, senior applications engineer at SPX Flow, sat down with Biopharm International to discuss scale up from lab to commercial scale.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
